Galderma R&d

This study follows 1,000 teens and adults with moderate-to-severe atopic dermatitis (eczema) who are starting nemolizumab as part of their normal care. Researchers will check how well the drug controls skin symptoms and itching after 6 months using doctor ratings and patient surv…

This study tests a drug called nemolizumab in 50 adults with chronic itching that has no clear cause. The goal is to see how the drug moves through the body and how well it reduces itching over 16 weeks. Participants must be 18 or older and have had unexplained itching for at lea…

This study tests a prescription cream called trifarotene on Chinese people aged 9 and older with moderate acne on the face and upper body. About 561 participants will apply the cream or a placebo daily for 12 weeks to see if it clears pimples and reduces breakouts. The goal is to…

This study tests whether an injectable filler called Sculptra 011611 can safely improve the look of skin irregularities on the buttocks, like dimples or laxity. About 125 women with moderate to severe skin looseness will either get the treatment or no treatment at all. Doctors wi…

This study looks at how well nemolizumab works in real-world clinics for adults with moderate-to-severe prurigo nodularis, a condition causing itchy skin bumps. Researchers will track changes in itch severity and skin lesion scores over 6 months. The goal is to see if the drug he…

This study looks at how a treatment called poly L-lactic acid (PLLA) changes proteins in the skin of menopausal women with cheek wrinkles. About 40 women will receive the treatment, and small skin samples will be taken to measure these changes. The goal is to understand how the t…

This study looks at how a biostimulator called Sculptra changes the structure of skin in the cheek area. Researchers will use special cameras and imaging tools to compare before and after pictures. The goal is to understand the skin changes, not to test a new treatment. About 25 …